Ethereum slips below $3,000 – Why are whales quietly buying the dip?

ambcryptoPublished on 2026-01-21Last updated on 2026-01-21

Abstract

Ethereum's price fell below $3,000 amid a broader crypto market decline, driven by global political tensions and risk-off sentiment. Despite the drop, on-chain data reveals that large investors, or "whales," are actively accumulating ETH around the $3,000 level. A major institution, Trend Research, borrowed $70M to purchase over 24,500 ETH, while another whale bought 20,000 ETH via OTC desks—reducing immediate sell pressure and potentially setting the stage for a future supply shock. However, the use of leverage introduces risk, as a drop to $2,500–$2,600 could trigger liquidations. Although network activity appears strong, much of it is artificial due to address poisoning attacks. The underlying dynamics suggest cautious optimism for long-term bulls.

The crypto market is getting a harsh reminder of how global politics can affect financial markets.

U.S. President Trump’s recent tariff actions, including tensions linked to Greenland, have pushed investors into a clear risk-off mode.

As a result, the total crypto market value had fallen to around $3 trillion at press time, per CoinMarketCap data. Additionally, the Fear & Greed Index dropped to 32, showing growing caution across the market.

Ethereum [ETH] has not been immune to this pressure. Its price has slipped to about $2,964.

However, something unusual is happening beneath the surface. While prices are falling, activity on the Ethereum network remains strong.

This suggests some investors are starting to separate Ethereum’s role as long-term infrastructure from short-term price swings.

Whales step in around $3,000

Retail investors appear to be selling, but large players are doing the opposite. On-chain data from Lookonchain shows that major investors are aggressively buying Ethereum around current price levels.

Many see the $2,900–$3,000 range as a buying opportunity rather than a danger zone.

One of the biggest moves came from Trend Research, a large institutional player. The firm borrowed $70 million in USDT from Aave and used it to buy 24,555 ETH, worth about $75.5 million.

With this move, Trend Research now holds more than 651,000 ETH, valued at roughly $1.9 billion. This massive position acts as a psychological support level for the market, often referred to as a buy wall.

OTC buying reduces sell pressure

That being said, Trend Research is not alone.

Another large investor was recently seen buying 20,000 ETH, worth nearly $59 million, through over-the-counter (OTC) desks such as FalconX and Wintermute.

Buying through OTC desks matters because it does not immediately affect exchange prices.

Once these ETH tokens move into private wallets or are locked in DeFi platforms like Aave, they are effectively removed from the open market.

This reduces the amount of ETH available for selling.

When demand returns, a lower supply can lead to sharp price increases, often leading to a supply shock.

The risk of leverage

However, there is a downside to this strategy. Trend Research is using borrowed funds to buy ETH.

This means its position depends on Ethereum staying above certain price levels. If ETH falls into the $2,500–$2,600 range, these positions could face liquidation.

Forced selling by large players could trigger a rapid decline in price, where buyers are forced to sell into a falling market.

Network activity is not what it seems

This coincided with AMBCrypto’s recent analysis of Ethereum’s network activity, which looked strong at first glance. New addresses were up 2.7 times, and weekly transactions have hit a record 17.1 million.

But research shows that about 80% of this growth is artificial. Much of the activity comes from an increase in address poisoning attacks.

Thus, while Ethereum’s outlook for 2026 remains uncertain, underlying metrics point to a possible shift back in favor of bulls.


Final Thoughts

  • Ethereum’s current dip reflects fear, not collapse, as large investors continue to build positions quietly.
  • Investors must look beyond price and headline metrics, focusing on supply, leverage, and real network usage.

Related Questions

QWhat is the main reason behind the recent decline in the crypto market, including Ethereum's drop below $3,000?

AThe decline is primarily attributed to global political tensions, specifically U.S. President Trump's recent tariff actions and tensions linked to Greenland, which pushed investors into a risk-off mode.

QHow are large investors (whales) responding to Ethereum's price dip around the $3,000 level?

ALarge investors are aggressively buying Ethereum. For example, Trend Research borrowed $70 million to purchase 24,555 ETH, and another whale bought 20,000 ETH through OTC desks, viewing the $2,900–$3,000 range as a buying opportunity.

QWhy does buying Ethereum through Over-The-Counter (OTC) desks reduce sell pressure on the market?

AOTC purchases do not immediately affect exchange prices. Once the ETH is moved to private wallets or locked in DeFi platforms, it is removed from the open market, reducing the available supply for selling and potentially leading to a supply shock when demand returns.

QWhat is the major risk associated with Trend Research's strategy of using borrowed funds to buy Ethereum?

AThe major risk is leverage. If Ethereum's price falls into the $2,500–$2,600 range, these leveraged positions could face liquidation, potentially triggering forced selling and a rapid price decline.

QAccording to the article, what does the analysis reveal about the recent surge in Ethereum's network activity?

AThe analysis reveals that about 80% of the recent growth in network activity, including new addresses and record weekly transactions, is artificial and largely driven by an increase in address poisoning attacks.

Related Reads

Banks Battle Stablecoins: Where Will Deposits Ultimately Flow?

"Banks vs. Stablecoins: Where Will Deposits Flow?" By: Prathik Desai The traditional banking model, where banks profit from lending out low-interest deposits, faces a fundamental challenge from blockchain-based stablecoins. While U.S. savings accounts offer ~0.6% interest, stablecoins provide near-instant, low-cost global transfers and, via DeFi protocols, access to 5-8% yields. This threatens bank deposit bases and their net interest margins. History offers a parallel: In the 1970s, Merrill Lynch's Cash Management Account (CMA) circumvented Regulation Q's interest caps by sweeping funds into money market funds, causing massive deposit outflows until banks responded with their own high-yield accounts. Today, two competing "digital dollar" models are emerging: 1. **Stablecoins (e.g., USDC):** Funds leave the banking system to back the tokens. While laws like the GENIUS Act forbid issuers from paying interest, users can earn yield via DeFi. This poses an existential threat, especially to regional banks. Predictions suggest significant deposit migration to stablecoins. 2. **Tokenized Deposits:** Banks convert deposits into on-chain tokens for fast, cheap transfers, while the original funds remain on their balance sheets, protected by FDIC insurance and available for lending. Two major bank consortia are developing platforms: one for institutions (led by JPMorgan, Citi, etc.) and Cari Network (regional banks) for retail users. The competition centers on control. Stablecoins offer openness and programmability but lack insurance. Tokenized deposits offer safety and yield but within the traditional, regulated system. A third path, exemplified by SoFi Bank's launch of SoFiUSD, aims to bridge this divide. SoFi integrates a stablecoin, a tokenized deposit (with yield and FDIC insurance), and a bank account in one app, allowing seamless switching based on the user's need for yield, safety, or liquidity. The core insight is that the future belongs not to a single product form, but to the *ability to frictionlessly switch* between forms—optimizing for security, yield, or liquidity as needed. Blockchain technology is becoming financial infrastructure, not to replace banks, but to force them to deconstruct and rebuild their services. The ultimate winners will be institutions that enable this seamless conversion, forcing an evolution similar to the post-Regulation Q era, where traditional finance absorbed innovations to survive.

Foresight News7m ago

Banks Battle Stablecoins: Where Will Deposits Ultimately Flow?

Foresight News7m ago

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

Exclusive | ByteDance’s AI Drug Discovery Unit Initiates Spin-off for Financing, Signaling Industrialization Phase for AI4S. ByteDance’s AI drug discovery business line has begun the process of spinning off as an independent entity to raise outside funding, marking a key step toward industrializing its AI for Science (AI4S) efforts. Post-spin-off, ByteDance will remain the controlling shareholder. The new company will inherit the core team, algorithms, technology platform, and existing pipeline assets. It will also continue to receive computing power support from ByteDance's Volcano Engine. The AI drug discovery team, established in 2021 and led by Liu Kai with a core team of about 50 AI and pharmaceutical experts, has been responsible for foundational model research and industrialization. It has consolidated ByteDance's protein structure prediction model team and launched several key technologies. These include the molecular structure prediction models Protenix and Seedfold, the protein design tool PXDesign, and the AI drug discovery platform "Anew Labs." Anew Labs has produced research covering protein-ligand dynamics, molecular generation, and free energy calculation, and has developed early-stage drug pipelines like IL-17 and IL4R inhibitors. Notably, its IL-17 small molecule program, presented in April 2026, demonstrated the first small-molecule blockade of three IL-17 dimers, a significant step in autoimmune disease research. This progress demonstrates ByteDance’s AI capabilities have advanced from model development to validating specific drug targets and molecules. The company believes the opportunity to transition from research to industry is now ripe. The spin-off aims to establish an organizational structure better suited to the business's unique needs—long R&D cycles and complex validation processes involving wet labs and clinical trials—to attract top talent and drive deeper integration of AI with the pharmaceutical industry. The move responds to the pharmaceutical industry's pressing need to improve efficiency amid high R&D costs, long timelines, and high failure rates. The field of AI4S is rapidly advancing, as seen with tools like AlphaFold evolving from protein prediction to modeling complex biological interactions and the emergence of multimodal molecular generation models for drug design. ByteDance has been building its AI4S capabilities for years, exploring areas like computational biology, molecular simulation, and materials science. This spin-off represents its first major attempt to industrialize AI4S. An insider stated the company attaches great importance to this move, hoping that an independent entity with greater decision-making flexibility can pioneer a viable industrial path for AI4S in China.

marsbit45m ago

Exclusive | ByteDance's AI Drug Discovery Unit Initiates Spinoff and Funding, AI4S Enters Industrialization Phase

marsbit45m ago

Galaxy Deep Dive: How Does Hyperliquid's HIP-4 Upgrade Change the Predictive Markets Landscape?

Galaxy Research Report: How Hyperliquid's HIP-4 Upgrade Changes the Prediction Market Landscape. Hyperliquid's HIP-4 protocol upgrade, activated on May 2, introduces a third model for prediction markets. While incumbents like Polymarket focus on consumer discovery and Kalshi on regulated US access, HIP-4 integrates outcome markets directly into Hyperliquid's "house of all finance." This embeds binary event contracts within HyperCore, its native on-chain order book, sharing a single margin account with perpetual and spot trading. HIP-4 offers distinct advantages: superior infrastructure with sub-second finality, ~200k orders/sec throughput, and unified cross-margin, enabling novel hedges for perpetual traders. It also features a unique validator-curated oracle model for off-chain events (e.g., Fed decisions, CPI, sports) and zero fees on opening positions. Early traction shows HIP-4 capturing ~20% of combined BTC prediction market volume within 25 days. The report highlights a broader industry trend of convergence: all major platforms are moving towards a "trade everything from one account" model. HIP-4's challenge lies in expanding market breadth and consumer discovery, currently lagging behind Polymarket's flexible UMA oracle/Kalshi's sports depth. Key risks include validator centralization, US regulatory exposure (mitigated by potential pathways like the CLARITY Act), and competitive pressure from Kalshi's newly CFTC-approved Bitcoin perpetual contract. Ultimately, HIP-4's strongest case is its technically superior, unified execution stack—a harder advantage for competitors to replicate than building consumer layers atop it. The upgrade positions Hyperliquid to contest the lucrative institutional hedging flow in the evolving prediction market arena.

marsbit1h ago

Galaxy Deep Dive: How Does Hyperliquid's HIP-4 Upgrade Change the Predictive Markets Landscape?

marsbit1h ago

Trading

Spot
Futures

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of ETH (ETH) are presented below.

活动图片